下一代口服输送系统:通过REGEMAT 3D生物打印机的3D打印来增强生物可用性,通过Phytosomal Hinokitiol药片
Turky Omar Asar1, Ghada A Milibary2, Alshaimaa M Almehmady2
1Department of Biology, College of Science and Arts at Alkamil, University of Jeddah, Jeddah, Saudi Arabia.
Scientifica
|July 15, 2025
概括
这项研究开发了3D打印的平板电脑,其中含有hinocitiol的植物体,显著提高了hinocitiol在潜在的乳腺癌治疗中的生物可用性和治疗疗效. 这种新型配方增强了药物释放和药物动力学性能.
科学领域:
- 制药技术 制药技术 制药技术
- 纳米技术 纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 欣诺基,一种天然化合物,显示出有前途的治疗方法,特别是在乳腺癌.
- 溶解度差和生物利用度低限制了欣诺基的临床使用.
- 以前的液体植物体配方需要增强,以更好地输送药物.
研究的目的:
- 开发3D打印的口服药片,其中包含含希诺基醇的植物体.
- 为了提高欣诺基的药理动力学性能和治疗疗效.
- 为难溶性生物活性化合物创建一种新型药物输送系统.
主要方法:
- 使用基于基基甲基纤维素的糊剂与纯基或基载荷的植物体3D打印3D打印片的配方.
- 质量控制测试:重量变化,厚度,药物含量,易碎性和体外溶解.
- 使用扫描电子显微镜,分子对接,分子动力学模拟和大鼠的药理动力学评估进行了表征.
主要成果:
- 带有植物体的药片表现出更密集的结构和更好的药物释放概况.
- 分子模拟证实了基和标蛋白之间的稳定相互作用,这表明了抗癌机制.
- 在体外溶解和体内药理学研究表明,从含有植物体的片中释放药物和生物可用性优越.
结论:
- 3D打印的平板电脑带有含有欣诺基的植物体构成了一个有前途的药物输送系统.
- 这种方法显著提高了欣诺基的生物可用性,药物释放和治疗疗效.
- 纳米技术和3D打印的整合为改善难溶药物的临床应用提供了一个可行的策略.
相关概念视频
01:16Drug Delivery: Overview
427
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
427
01:18Drug Delivery: Enteral Route
743
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
743
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.6K
01:24Factors Influencing Drug Absorption: Presystemic Elimination
350
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
350
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
268
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
268